Resource

 

 

 

 

 

 

 

 

 

 

 

Finance & Banking

WFW advises ING Bank on €19m loan facility to Borusan

02 Mar 2019
Watson Farley & Williams ("WFW") has advised ING Bank ("ING"), a branch of ING-DiBA AG, as lender, facility agent, and mandated lead arranger on a circa EU19m multi-tranche loan facility to Borusan Mannesmann Boru. San. Ve. Tic. A.S, a member of the Borusan group for the financing of construction materials and services from Austrian exporters to be used in steel production plants located in Gemlik and Halkali, Turkey.

FIRM CAPITAL MORTGAGE INVESTMENT CORPORATION CLOSES $23 MILLION BOUGHT DEAL FINANCING

02 Mar 2019

On March 1, 2019, Firm Capital Mortgage Investment Corporation (TSX: FC) announced that it had closed its previously announced bought deal offering of common shares, which includes the exercise in full by the underwriters of their option to purchase additional shares, for gross proceeds of approximately $23 million.

 

WFW advises Investec on construction financing of subsidy-free 34.7MW tracker solar photovoltaic project

01 Mar 2019

Watson Farley & Williams (“WFW”) has advised Investec Bank plc (“Investec”) on the construction financing for a 34.7MW solar photovoltaic project near York. The loan documentation was signed on 22 February.

 

The project, which will be constructed by GRIDSERVE WBC Ltd (a subsidiary of GRIDSERVE EMEA Projects Ltd), has a co-located battery and will be fully subsidy-free. Following completion, the project will be sold to Warrington Borough Council to support its green agenda and save on electricity costs.

 

Osborne Clarke advises BFB Brandenburg Kapital GmbH on investment in Cinuru Research

28 Feb 2019

Osborne Clarke has advised BFB Brandenburg Kapital GmbH, a subsidiary of Brandenburger Förderbank ILB, on its investment in Cinuru Research GmbH. Further investors are Next Media Accelerator (NMA) from Hamburg and a business angel. The seven-figure investment will be used for further growth and technological development of the CRM system for cinemas.

Clifford Chance advises CACEIS on a EUR 188 million public offer for all issued shares and depositary receipts of shares in the capital of Kas Bank

28 Feb 2019

Clifford Chance Amsterdam advised long-term firm client CACEIS, European leader in asset servicing, on a EUR 188 million public offer for all issued shares and depositary receipts of shares in the capital of Kas Bank N.V, a specialist in the field of custody and administration services.

WFW advises KfW IPEX-Bank on financing of “La Granja Solar” Chilean photovoltaic project

27 Feb 2019

Watson Farley & Williams ("WFW") has advised KfW IPEX-Bank GmbH ("KfW IPEX-Bank") on the US$91m financing for the Granja Solar photovoltaic project near Pozo Almonte in northern Chile. The loan documentation was signed in December 2018.

"La Granja Solar" was developed by Spain's Getxo headquartered Solarpack Corporacion Tecnologica, S.A., which will also be building, owning and operating the project. Following completion, Granja Solar will have a total installed capacity of 123 MWp.

Norton Rose Fulbright advises on the €200 million refinancing of a shopping centre in Warsaw

27 Feb 2019

Global law firm Norton Rose Fulbright has advised Commerzbank AG on the EU200 million loan facility made available to Unibail-Rodamco-Westfield controlled entity for the purpose of refinancing of Galeria Mokotow - one of the largest shopping centres in Warsaw, Poland, opened in September 2000.

Unibail-Rodamco-Westfield is a leading real estate firm involved in real estate investment, development and commercial property management worldwide.

Baker McKenzie advisor to Vator Securities in connection with Ascelia Pharma’s IPO on Nasdaq Stockholm

26 Feb 2019

Ascelia Pharma intends to carry out a new share issue prior to the company’s listing on Nasdaq Stockholm. The share issue is expected to provide Ascelia Pharma with a total of approximately SEK 212 million after deductions for expenses related to the transaction. The first day of trading is expected to be March 13, 2019.

Ascelia Pharma is an oncology-dedicated orphan drug development company located in Malmö, Sweden.